Updated 4-Year Results for NRG Oncology/RTOG 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer
Year: 2016
Type: article
Authors: A.N. Viswanathan, K. Winter, B.E. Miller, Y. Xiao, A. Jhingran, L. Portelance, W.R. Bosch, U. Matulonis, N. Horowitz, R. Mannel, L. Souhami, B.A. Erickson, W. Small, D.K. Gaffney
Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, NRG Oncology, Carolinas Medical Center, University of Pennsylvania, The University of Texas MD Anderson Cancer Center, University of Miami, Sylvester Comprehensive Cancer Center, Washington University in St. Louis, OU Health, University of Oklahoma Health Sciences Center, McGill University Health Centre, Medical College of Wisconsin, Loyola University Chicago, University of Utah, Huntsman Cancer Institute
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2525196763